Quantum-Si Incorporated (Nasdaq: QSI), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it will participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financial Officer, will participate in a virtual fireside chat on Thursday, November 18, 2021 at 2:30 p.m. ET.

A webcast of the event will be available on the Investors section of Quantum-Si’s website under Events & Presentations. A replay will be available on the Company’s website after the event.

About Quantum-Si

Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

Investor Contacts Juan Avendano VP of Investor Relations (413) 537-8735 javendano@quantum-si.com Mike Cavanaugh ICR Westwicke (617) 877-9641 ir@quantum-si.com Media Contact Cammy Duong ICR Westwicke (203) 682-8380 QSI-PR@westwicke.com

Quality Systems (NASDAQ:QSII)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Quality Systems.
Quality Systems (NASDAQ:QSII)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Quality Systems.